Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in Multi-ligament Knee Injury
NCT06933706Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Oct 2025
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in multi-ligament knee injury (MLKI), sponsored by Brigham and Women's Hospital. Started Oct 2025; status: recruiting.
02
Drugs
losartan
03
Conditions
multi-ligament knee injury (MLKI)
Beyond the preview
Go deeper on NCT06933706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06933706.